This opportunity is a 100% small business set-aside for multi-omics services to support a VA-funded study on degenerative cervical myelopathy, with performance at the contractor’s facility. The contractor must provide transcriptomics, proteomics, metabolomics, and integrated bioinformatics analysis under a single chain of custody to minimize batch effects. The period of performance is one 12-month term from the date of award, and a firm-fixed price contract will be awarded. No specific budget amount is stated in the description. The place of performance is the contractor’s facility, with no access to VA systems required.